Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS)
CNY 6.51
(1.4%)
CNY 6.51
(1.4%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 361.03 Million CNY | 12.25% |
| 2022 | 321.64 Million CNY | -20.6% |
| 2021 | 405.09 Million CNY | 132.8% |
| 2020 | 174 Million CNY | -49.09% |
| 2019 | 341.81 Million CNY | -21.97% |
| 2018 | 438.07 Million CNY | -39.61% |
| 2017 | 725.35 Million CNY | -3.08% |
| 2016 | 748.39 Million CNY | 10.27% |
| 2015 | 678.7 Million CNY | 25.5% |
| 2014 | 540.78 Million CNY | 24.64% |
| 2013 | 433.89 Million CNY | 19.23% |
| 2012 | 363.91 Million CNY | 34.22% |
| 2011 | 271.13 Million CNY | 67.14% |
| 2010 | 162.22 Million CNY | 90.07% |
| 2009 | 85.34 Million CNY | 43.53% |
| 2008 | 59.46 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 51.12 Million CNY | -27.75% |
| 2024 Q3 | 56.44 Million CNY | 13.73% |
| 2024 Q1 | 70.75 Million CNY | -13.8% |
| 2023 Q4 | 82.08 Million CNY | -2.35% |
| 2023 Q1 | 89.2 Million CNY | 11.23% |
| 2023 FY | 361.03 Million CNY | 12.25% |
| 2023 Q2 | 105.68 Million CNY | 18.47% |
| 2023 Q3 | 84.06 Million CNY | -20.46% |
| 2022 Q3 | 74.79 Million CNY | 4.03% |
| 2022 FY | 321.64 Million CNY | -20.6% |
| 2022 Q1 | 94.73 Million CNY | -3.97% |
| 2022 Q2 | 71.9 Million CNY | -24.11% |
| 2022 Q4 | 80.2 Million CNY | 7.22% |
| 2021 Q2 | 93.24 Million CNY | -2.32% |
| 2021 Q4 | 98.66 Million CNY | -16.19% |
| 2021 FY | 405.09 Million CNY | 132.8% |
| 2021 Q1 | 95.46 Million CNY | 77.61% |
| 2021 Q3 | 117.72 Million CNY | 26.24% |
| 2020 Q1 | 31.7 Million CNY | -54.63% |
| 2020 FY | 174 Million CNY | -49.09% |
| 2020 Q2 | 32.14 Million CNY | 1.38% |
| 2020 Q4 | 53.75 Million CNY | -4.7% |
| 2020 Q3 | 56.4 Million CNY | 75.47% |
| 2019 FY | 341.81 Million CNY | -21.97% |
| 2019 Q4 | 69.88 Million CNY | -27.12% |
| 2019 Q3 | 95.88 Million CNY | 31.46% |
| 2019 Q2 | 72.93 Million CNY | -29.27% |
| 2019 Q1 | 103.11 Million CNY | 49.26% |
| 2018 Q1 | 137.11 Million CNY | -27.27% |
| 2018 FY | 438.07 Million CNY | -39.61% |
| 2018 Q3 | 124.13 Million CNY | 15.22% |
| 2018 Q4 | 69.08 Million CNY | -44.35% |
| 2018 Q2 | 107.73 Million CNY | -21.43% |
| 2017 Q4 | 188.52 Million CNY | -17.95% |
| 2017 Q2 | 152.86 Million CNY | -0.87% |
| 2017 FY | 725.35 Million CNY | -3.08% |
| 2017 Q3 | 229.77 Million CNY | 50.32% |
| 2017 Q1 | 154.19 Million CNY | -17.22% |
| 2016 Q2 | 168.61 Million CNY | -14.08% |
| 2016 Q4 | 186.28 Million CNY | -5.55% |
| 2016 Q1 | 196.25 Million CNY | 26.04% |
| 2016 Q3 | 197.23 Million CNY | 16.97% |
| 2016 FY | 748.39 Million CNY | 10.27% |
| 2015 Q4 | 155.7 Million CNY | -7.06% |
| 2015 Q3 | 167.54 Million CNY | -10.12% |
| 2015 Q2 | 186.4 Million CNY | 10.27% |
| 2015 FY | 678.7 Million CNY | 25.5% |
| 2015 Q1 | 169.04 Million CNY | 37.78% |
| 2014 FY | 540.78 Million CNY | 24.64% |
| 2014 Q4 | 122.69 Million CNY | -17.27% |
| 2014 Q3 | 148.32 Million CNY | 5.62% |
| 2014 Q2 | 140.42 Million CNY | 8.57% |
| 2014 Q1 | 129.33 Million CNY | 21.96% |
| 2013 Q3 | 124.48 Million CNY | 22.87% |
| 2013 Q1 | 102.04 Million CNY | 0.0% |
| 2013 FY | 433.89 Million CNY | 19.23% |
| 2013 Q4 | 106.04 Million CNY | -14.81% |
| 2013 Q2 | 101.31 Million CNY | -0.72% |
| 2012 FY | 363.91 Million CNY | 34.22% |
| 2011 Q4 | 77.44 Million CNY | 0.0% |
| 2011 FY | 271.13 Million CNY | 67.14% |
| 2010 FY | 162.22 Million CNY | 90.07% |
| 2009 FY | 85.34 Million CNY | 43.53% |
| 2008 FY | 59.46 Million CNY | 0.0% |